Hedge Fund - Logos Capital
Akero Therapeutics Inc. (AKRO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $48,576,000 | 8.64% | 1,200,000 | $42.39 |
| 2 | 2024 - Q4 (2024-12-31) | $22,256,000 | 2.6% | 800,000 | $30.29 |
| 3 | 2024 - Q3 (2024-09-30) | $22,952,000 | 2.47% | 800,000 | $26.07 |
| 4 | 2024 - Q2 (2024-06-30) | $18,768,000 | 1.5% | 800,000 | $21.39 |
| 5 | 2024 - Q1 (2024-03-31) | $20,208,000 | 1.63% | 800,000 | $24.02 |
| 6 | 2023 - Q4 (2023-12-31) | $18,680,000 | 1.74% | 800,000 | $19.72 |
| 7 | 2023 - Q3 (2023-09-30) | $30,348,000 | 4.04% | 600,000 | $46.56 |
| 8 | 2023 - Q2 (2023-06-30) | $24,278,800 | 3.3% | 520,000 | $45.83 |
| 9 | 2023 - Q1 (2023-03-31) | $15,304,000 | 2.19% | 400,000 | $44.58 |
| 10 | 2022 - Q4 (2022-12-31) | $21,920,000 | 2.56% | 400,000 | $42.85 |
| 11 | 2022 - Q3 (2022-09-30) | $13,620,000 | 1.67% | 400,000 | $15.30 |
The displayed share prices are average quarterly stock market prices.